Selected research
Industry Growth & Trends
Global AI Pathology Image Analysis System Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global AI Pathology Image Analysis System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for AI Pathology Image Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for AI Pathology Image Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Pathology Image Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the AI Pathology Image Analysis System market include Roche, Proscia, Indica Labs, Visiopharm, Aiforia, Lunit, Deep Bio, Mindpeak and Techcyte, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global AI Pathology Image Analysis System market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The AI Pathology Image Analysis System market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Pathology Image Analysis System market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Pathology Image Analysis System.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global AI Pathology Image Analysis System market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
AI Pathology Image Analysis System Market by Company
Roche
Proscia
Indica Labs
Visiopharm
Aiforia
Lunit
Deep Bio
Mindpeak
Techcyte
Qritive
Deciphex
Owkin
Aiosyn
DoMore Diagnostics
Stratipath
AIRA Matrix
Tribun Health
PathAI
Paige
Ibex Medical Analytics
AI Pathology Image Analysis System Segment by Type
Task-Specific AI Algorithms
Modular Image Analysis Suites
End-to-End AI Pathology Platforms
AI Model Development Platforms
AI-Enabled Image Management Systems
AI Pathology Image Analysis System Segment by Application
Cancer Diagnosis and Grading
Biomarker Scoring and Companion Diagnostics
Prognosis and Treatment Selection
Drug Discovery and Clinical Trials
Preclinical Safety Assessment
Pathology Workflow and Quality Control
AI Pathology Image Analysis System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pathology Image Analysis System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Pathology Image Analysis System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pathology Image Analysis System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of AI Pathology Image Analysis System companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Task-Specific AI Algorithms
- Modular Image Analysis Suites
- End-to-End AI Pathology Platforms
- AI Model Development Platforms
- AI-Enabled Image Management Systems
Applications
- Cancer Diagnosis and Grading
- Biomarker Scoring and Companion Diagnostics
- Prognosis and Treatment Selection
- Drug Discovery and Clinical Trials
- Preclinical Safety Assessment
- Pathology Workflow and Quality Control
Companies covered
- Roche
- Proscia
- Indica Labs
- Visiopharm
- Aiforia
- Lunit
- Deep Bio
- Mindpeak
- Techcyte
- Qritive
- Deciphex
- Owkin
- Aiosyn
- DoMore Diagnostics
- Stratipath
- AIRA Matrix
- Tribun Health
- PathAI
- Paige
- Ibex Medical Analytics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global AI Pathology Image Analysis System Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global AI Pathology Image Analysis System Market Size by Region (2021-2032)
- 1.4.1 Global AI Pathology Image Analysis System Market Size by Region (2021-2026)
- 1.4.2 Global AI Pathology Image Analysis System Market Size by Region (2027-2032)
- 1.5 Key Regions AI Pathology Image Analysis System Market Size (2021-2032)
- 1.5.1 North America AI Pathology Image Analysis System Market Size Growth Rate (2021-2032)
- 1.5.2 Europe AI Pathology Image Analysis System Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific AI Pathology Image Analysis System Market Size Growth Rate (2021-2032)
- 1.5.4 South America AI Pathology Image Analysis System Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa AI Pathology Image Analysis System Market Size Growth Rate (2021-2032)
2 AI Pathology Image Analysis System Market by Type
- 2.1 Type Introduction
- 2.1.1 Task-Specific AI Algorithms
- 2.1.2 Modular Image Analysis Suites
- 2.1.3 End-to-End AI Pathology Platforms
- 2.1.4 AI Model Development Platforms
- 2.1.5 AI-Enabled Image Management Systems
- 2.2 Global AI Pathology Image Analysis System Market Size by Type
- 2.2.1 Global AI Pathology Image Analysis System Market Size Overview by Type (2021-2032)
- 2.2.2 Global AI Pathology Image Analysis System Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global AI Pathology Image Analysis System Market Size Forecasted by Type (2027-2032)
- 2.3 Global AI Pathology Image Analysis System Market Size by Regions
- 2.3.1 North America AI Pathology Image Analysis System Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe AI Pathology Image Analysis System Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific AI Pathology Image Analysis System Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America AI Pathology Image Analysis System Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa AI Pathology Image Analysis System Market Size Breakdown by Type (2021-2026)
3 AI Pathology Image Analysis System Market by Application
- 3.1 Type Introduction
- 3.1.1 Cancer Diagnosis and Grading
- 3.1.2 Biomarker Scoring and Companion Diagnostics
- 3.1.3 Prognosis and Treatment Selection
- 3.1.4 Drug Discovery and Clinical Trials
- 3.1.5 Preclinical Safety Assessment
- 3.1.6 Pathology Workflow and Quality Control
- 3.2 Global AI Pathology Image Analysis System Market Size by Application
- 3.2.1 Global AI Pathology Image Analysis System Market Size Overview by Application (2021-2032)
- 3.2.2 Global AI Pathology Image Analysis System Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global AI Pathology Image Analysis System Market Size Forecasted by Application (2027-2032)
- 3.3 Global AI Pathology Image Analysis System Market Size by Regions
- 3.3.1 North America AI Pathology Image Analysis System Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe AI Pathology Image Analysis System Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific AI Pathology Image Analysis System Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America AI Pathology Image Analysis System Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa AI Pathology Image Analysis System Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 AI Pathology Image Analysis System Industry Trends
- 4.2 AI Pathology Image Analysis System Industry Drivers
- 4.3 AI Pathology Image Analysis System Industry Opportunities and Challenges
- 4.4 AI Pathology Image Analysis System Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by AI Pathology Image Analysis System Revenue (2021-2026)
- 5.2 Global AI Pathology Image Analysis System Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global AI Pathology Image Analysis System Key Company Headquarters & Area Served
- 5.4 Global AI Pathology Image Analysis System Company, Product Type & Application
- 5.5 Global AI Pathology Image Analysis System Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global AI Pathology Image Analysis System Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 AI Pathology Image Analysis System Players Market Share by Revenue in 2025
- 5.6.3 2025 AI Pathology Image Analysis System Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Roche
- 6.1.1 Roche Company Information
- 6.1.2 Roche Business Overview
- 6.1.3 Roche AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Roche AI Pathology Image Analysis System Product Portfolio
- 6.1.5 Roche Recent Developments
- 6.2 Proscia
- 6.2.1 Proscia Company Information
- 6.2.2 Proscia Business Overview
- 6.2.3 Proscia AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Proscia AI Pathology Image Analysis System Product Portfolio
- 6.2.5 Proscia Recent Developments
- 6.3 Indica Labs
- 6.3.1 Indica Labs Company Information
- 6.3.2 Indica Labs Business Overview
- 6.3.3 Indica Labs AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Indica Labs AI Pathology Image Analysis System Product Portfolio
- 6.3.5 Indica Labs Recent Developments
- 6.4 Visiopharm
- 6.4.1 Visiopharm Company Information
- 6.4.2 Visiopharm Business Overview
- 6.4.3 Visiopharm AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Visiopharm AI Pathology Image Analysis System Product Portfolio
- 6.4.5 Visiopharm Recent Developments
- 6.5 Aiforia
- 6.5.1 Aiforia Company Information
- 6.5.2 Aiforia Business Overview
- 6.5.3 Aiforia AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Aiforia AI Pathology Image Analysis System Product Portfolio
- 6.5.5 Aiforia Recent Developments
- 6.6 Lunit
- 6.6.1 Lunit Company Information
- 6.6.2 Lunit Business Overview
- 6.6.3 Lunit AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Lunit AI Pathology Image Analysis System Product Portfolio
- 6.6.5 Lunit Recent Developments
- 6.7 Deep Bio
- 6.7.1 Deep Bio Company Information
- 6.7.2 Deep Bio Business Overview
- 6.7.3 Deep Bio AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Deep Bio AI Pathology Image Analysis System Product Portfolio
- 6.7.5 Deep Bio Recent Developments
- 6.8 Mindpeak
- 6.8.1 Mindpeak Company Information
- 6.8.2 Mindpeak Business Overview
- 6.8.3 Mindpeak AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Mindpeak AI Pathology Image Analysis System Product Portfolio
- 6.8.5 Mindpeak Recent Developments
- 6.9 Techcyte
- 6.9.1 Techcyte Company Information
- 6.9.2 Techcyte Business Overview
- 6.9.3 Techcyte AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Techcyte AI Pathology Image Analysis System Product Portfolio
- 6.9.5 Techcyte Recent Developments
- 6.10 Qritive
- 6.10.1 Qritive Company Information
- 6.10.2 Qritive Business Overview
- 6.10.3 Qritive AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Qritive AI Pathology Image Analysis System Product Portfolio
- 6.10.5 Qritive Recent Developments
- 6.11 Deciphex
- 6.11.1 Deciphex Company Information
- 6.11.2 Deciphex Business Overview
- 6.11.3 Deciphex AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Deciphex AI Pathology Image Analysis System Product Portfolio
- 6.11.5 Deciphex Recent Developments
- 6.12 Owkin
- 6.12.1 Owkin Company Information
- 6.12.2 Owkin Business Overview
- 6.12.3 Owkin AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Owkin AI Pathology Image Analysis System Product Portfolio
- 6.12.5 Owkin Recent Developments
- 6.13 Aiosyn
- 6.13.1 Aiosyn Company Information
- 6.13.2 Aiosyn Business Overview
- 6.13.3 Aiosyn AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Aiosyn AI Pathology Image Analysis System Product Portfolio
- 6.13.5 Aiosyn Recent Developments
- 6.14 DoMore Diagnostics
- 6.14.1 DoMore Diagnostics Company Information
- 6.14.2 DoMore Diagnostics Business Overview
- 6.14.3 DoMore Diagnostics AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 DoMore Diagnostics AI Pathology Image Analysis System Product Portfolio
- 6.14.5 DoMore Diagnostics Recent Developments
- 6.15 Stratipath
- 6.15.1 Stratipath Company Information
- 6.15.2 Stratipath Business Overview
- 6.15.3 Stratipath AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Stratipath AI Pathology Image Analysis System Product Portfolio
- 6.15.5 Stratipath Recent Developments
- 6.16 AIRA Matrix
- 6.16.1 AIRA Matrix Company Information
- 6.16.2 AIRA Matrix Business Overview
- 6.16.3 AIRA Matrix AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 AIRA Matrix AI Pathology Image Analysis System Product Portfolio
- 6.16.5 AIRA Matrix Recent Developments
- 6.17 Tribun Health
- 6.17.1 Tribun Health Company Information
- 6.17.2 Tribun Health Business Overview
- 6.17.3 Tribun Health AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Tribun Health AI Pathology Image Analysis System Product Portfolio
- 6.17.5 Tribun Health Recent Developments
- 6.18 PathAI
- 6.18.1 PathAI Company Information
- 6.18.2 PathAI Business Overview
- 6.18.3 PathAI AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 PathAI AI Pathology Image Analysis System Product Portfolio
- 6.18.5 PathAI Recent Developments
- 6.19 Paige
- 6.19.1 Paige Company Information
- 6.19.2 Paige Business Overview
- 6.19.3 Paige AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Paige AI Pathology Image Analysis System Product Portfolio
- 6.19.5 Paige Recent Developments
- 6.20 Ibex Medical Analytics
- 6.20.1 Ibex Medical Analytics Company Information
- 6.20.2 Ibex Medical Analytics Business Overview
- 6.20.3 Ibex Medical Analytics AI Pathology Image Analysis System Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Ibex Medical Analytics AI Pathology Image Analysis System Product Portfolio
- 6.20.5 Ibex Medical Analytics Recent Developments
7 North America
- 7.1 North America AI Pathology Image Analysis System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America AI Pathology Image Analysis System Market Size by Country (2021-2026)
- 7.3 North America AI Pathology Image Analysis System Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe AI Pathology Image Analysis System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe AI Pathology Image Analysis System Market Size by Country (2021-2026)
- 8.3 Europe AI Pathology Image Analysis System Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AI Pathology Image Analysis System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific AI Pathology Image Analysis System Market Size by Country (2021-2026)
- 9.3 Asia-Pacific AI Pathology Image Analysis System Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America AI Pathology Image Analysis System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America AI Pathology Image Analysis System Market Size by Country (2021-2026)
- 10.3 South America AI Pathology Image Analysis System Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AI Pathology Image Analysis System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa AI Pathology Image Analysis System Market Size by Country (2021-2026)
- 11.3 Middle East & Africa AI Pathology Image Analysis System Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst